Search results
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 12 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 1 day agoGenmab and BioNTech announced the initial data from the phase II GCT1046-04 trial, which evaluated...
BioNTech gets $145 million funding for African vaccine plants
Reuters via AOL· 6 days agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
Pharmaceutical Technology via Yahoo Finance· 5 days agoBioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced an expansion...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 4 days agoThe NHS has commenced a clinical trial offering personalised cancer vaccines being developed by BioNTech and Genentech to patients. The first patient was...
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
Reuters· 6 days agoCOVID-19 vaccine maker BioNTech won up to $145 million in funding from a global coalition against...
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 4 days agoThe vaccine was created using mRNA technology – the same used in Covid jabs – and is being jointly...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoGenmab A/S (Nasdaq: GMAB, “Genmab”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced initial data from the ongoing Phase 2 trial (NCT05117242) ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoBiotech stock hit a two-year high in February, but have trended lower in the months since despite a...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 1 day agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...